#mifepristone

#mifepristone

Ulipristal acetate, a pill used for emergency contraception, may provide an alternative method for terminating early pregnancies in restrictive states.

Trump's abortion stance remains unclear, reflecting a strategy of ambiguity and potential outsourcing of policy to anti-abortion advocates.

Herb Geraghty plans to resume anti-abortion protests, highlighting the ongoing commitment of activists in response to the political landscape.

A Trump cabinet pick reportedly committed to reinstating anti-choice rules, aiming to limit access to mifepristone.

The renewed legal challenge against mifepristone threatens nationwide access to abortion medication.

The US Supreme Court ruling in Alliance for Hippocratic Medicine v. FDA does not conclude FDA's exclusive authority over drug regulation, leaving room for future challenges.

Louisiana's reclassification of abortion pills as controlled substances may hinder essential obstetric care, particularly in managing complications like postpartum hemorrhage.

The Supreme Court unanimously preserved access to mifepristone, a key medication in abortion, rejecting a challenge that could have limited its availability across the country.

The Supreme Court dismissed a major abortion-related case due to lack of legal standing, preserving access to mifepristone without ruling on the case's merits.

The ruling allows a lawsuit challenging the FDA's mifepristone regulation to continue, which could impact abortion access across the US.

Robert F. Kennedy Jr. pledged to follow Trump's stance on abortion pill regulations if confirmed as Health Secretary.

Ulipristal acetate may serve as a safe alternative to the abortion pill mifepristone.

Comptroller Brad Lander's push for mifepristone sales has drawn criticism from state financial officers for politicizing marketplace decisions.

Pharmacy chains CVS and Walgreens to start dispensing abortion pill mifepristone.

Mifepristone availability initially in select states with plans for expansion to all legal states.

Medication abortion with mifepristone and misoprostol is safe, effective, and widely used globally, with high patient satisfaction rates.

Trump commits to maintaining FDA access to abortion pills during his presidency, diverging from the anti-abortion agenda of some of his allies.

The Supreme Court will soon hear a case about the abortion drug mifepristone and its use in virtual appointments.

A study published in Nature Medicine provides support for the FDA's assessment that telehealth abortion is safe and effective.

The Supreme Court is considering FDA regulations on mifepristone.

Pre-2016 rules could limit access to medication abortion.

The safety of mifepristone is a central issue in the case challenging FDA approval.

Emergency room visits following medication abortion are not necessarily indicative of safety concerns.

The Supreme Court upheld nationwide access to the abortion pill mifepristone despite a lawsuit aiming to restrict it, leading to unintended positive effects on abortion access and awareness.

Conservative challengers targeting FDA decisions on mifepristone could impact access to other medications.

Supreme court case on mifepristone could reshape abortion access and drug regulation in the US.

The U.S. Supreme Court upheld access to mifepristone, a key abortion drug, with Justice Kavanaugh's decision.

Publisher Sage retracted three abortion studies cited by anti-abortion groups in a legal case.

The retraction was based on problems with the studies' methods, analyses, presentation, and undisclosed conflicts of interest.